Table of Contents Life Sciences & Pharma Moving Money and Drugs November 2, 2012 Share this content Stephen Sunderland Helen Chen Related Industries Industries Life Sciences & Pharma Biotech and Pharmaceuticals Capabilities Mergers & Acquisitions Acquisition Screening Target Identification Joint Ventures and Alliances Due Diligence Post-Merger Integration Exit Support Back to Up Next: Related insights You might also be interested in these insights. Financial Services US Customers Could Soon Get A Paypal Bank December 25, 2025 Healthcare Services 2026 health tech predictions: From AI scribes to digital pathology December 19, 2025 Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026 Financial Services Southeast Asia Business Partnerships – Three Steps for Success December 04, 2025 Life Sciences & Pharma Investing in Psychedelic Therapies: Market Challenges and Opportunities December 23, 2025 Industrials Energy transition: powering data centre growth October 10, 2025 Language English Back to top
Healthcare Services 2026 health tech predictions: From AI scribes to digital pathology December 19, 2025
Life Sciences & Pharma Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton January 14, 2026
Life Sciences & Pharma Investing in Psychedelic Therapies: Market Challenges and Opportunities December 23, 2025